SGAs are primarily intended for patients in whom clinically significant regurgitation is unlikely to occur
These medications can reduce hepatic fat content, improve liver enzymes, and potentially slow fibrosis progression
Medication may help reduce the constant urge to snack, making or eating smaller portions, and support better control around meals
The analysis revealed consistent gastrointestinal-related adverse events across all weight groups, including nausea, vomiting, decreased appetite, and weight loss
Custom Treatments & Formulas Custom IV + Glutathione 60 min | 2 medical credits Formulated to your current clinical picture
References Abbasi M, Sohail M, Minhas MU et al (2019) Novel biodegradable pH-sensitive hydrogels: an efficient controlled release system to manage ulcerative colitis